Isotopia Molecular Imaging and ARTMS announced the company's prostate-specific membrane antigen-11-based radiopharmaceutical has undergone has undergone multicurie labeling using cyclotrons. The radiolabeled kit demonstrated and radiochemical purity and six-hour stability